Patents for C07C 233 - Carboxylic acid amides (28,881) |
---|
10/24/2006 | US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents |
10/24/2006 | US7126001 Antiproliferative agents; antitumor agents |
10/24/2006 | US7125999 Process for producing organotitanium compound and process for addition reaction |
10/24/2006 | US7125910 Compounds and compositions for delivering active agents |
10/24/2006 | US7125892 Aryl aniline β2 adrenergic receptor agonists |
10/24/2006 | US7125869 Drugs for cosmetics for treatment of cardiovadcular disorders, receptors, immunology or lipid metabolism |
10/24/2006 | US7125852 Geranyl compounds |
10/24/2006 | CA2262451C Boronic compound complexing reagents and complexes |
10/24/2006 | CA2152089C Asymmetric process for preparing florfenicol, thiamphenicol, chloramphenicol, and oxazoline intermediates |
10/19/2006 | WO2006110668A1 Compounds which inhibit beta-secretase activity and methods of use thereof |
10/19/2006 | WO2006109654A1 Process for producing tricarboxylic acid tris(alkyl-substituted cyclohexylamide) |
10/19/2006 | WO2006109321A1 An improved process for the synthesis of palmidrol |
10/19/2006 | WO2006109075A2 Hydroxybenzamide derivatives and their use as inhibitors of hsp90 |
10/19/2006 | WO2006108712A1 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics |
10/19/2006 | WO2005089354A3 Apparatus and method for applying variable localized pressure to the human body |
10/19/2006 | WO2005087700A3 Bisphenyl compounds useful as vitamin d3 receptor agonists |
10/19/2006 | US20060235241 Process for the carbonylation of a conuugated diene |
10/19/2006 | US20060235074 Matrix metalloproteinase inhibitors |
10/19/2006 | US20060235073 Diamino-functional chalcones |
10/19/2006 | US20060235069 Benzamide modulators of metabotropic glutamate receptors |
10/19/2006 | US20060235057 Phenyl compounds |
10/19/2006 | CA2604291A1 Compounds which inhibit beta-secretase activity and methods of use thereof |
10/19/2006 | CA2598208A1 Tetrahydronaphthalene derivatives, processes for their preparation and their use as antiinflammatory agents |
10/18/2006 | EP1712543A1 Process for the synthesis of amids based on polyetheramins and (meth)acrylic acids |
10/18/2006 | EP1711455A2 Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof |
10/18/2006 | EP1711453A2 Polymer dispersions or solutions comprising 3,4 dihydroxyphenyl groups |
10/18/2006 | EP1086072B1 Process for the preparation of protected dihydroxypropyl trialkylammonium salts and derivatives thereof |
10/18/2006 | CN1849320A Process for the preparation of renzapride and intermediates thereof |
10/18/2006 | CN1849299A Process for the synthesis of 6-amino-4-(3-chloro-4-fluoro-phenylamino)-7-ethoxy-quinoline-3-carbonitrile |
10/18/2006 | CN1849298A Production of N-acyl compounds |
10/18/2006 | CN1849117A Entry inhibitors of the HIV virus |
10/18/2006 | CN1849068A Capsaicin derivates and the production and use thereof |
10/18/2006 | CN1280271C Arylphenyl-substituted cyclic keto-enols |
10/18/2006 | CN1280259C Aryl aniline beta-2 adrenergic receptor agonists |
10/18/2006 | CN1280258C Process for producing 4,5-diamino shikimic acid derivative |
10/17/2006 | US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
10/17/2006 | US7122556 Phenylalanine enamide derivatives |
10/17/2006 | CA2318527C Inhibitors of .alpha.4 mediated cell adhesion |
10/12/2006 | WO2006106727A1 Benzyloxypropylamine derivative |
10/12/2006 | WO2005117854A3 Aryl ketone compounds and compositions for delivering active agents |
10/12/2006 | WO2005095326A8 2-amino- and 2-thio-substituted 1,3-diaminopropanes |
10/12/2006 | US20060229473 Ligands |
10/12/2006 | US20060229470 Calcium receptor-active molecules |
10/12/2006 | CA2603030A1 Benzyloxypropylamine derivative |
10/11/2006 | EP1709155A2 Compounds and compositions for treating dysproliferative diseases, and methods of use thereof |
10/11/2006 | EP1709089A1 Water-and oil-repellent fluoroacrylates |
10/11/2006 | EP1708698A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders |
10/11/2006 | CN1845758A Aminoalkyl substituted esters and amides of fumaric acid for neutralising malodor |
10/11/2006 | CN1845741A TRP-P8 active compounds and therapeutic treatment methods |
10/11/2006 | CN1844087A Polymerisable benzophenone photoinitiator and its preparing method |
10/11/2006 | CN1844086A Process for producing acrylamide crystal |
10/11/2006 | CN1279040C Tryasolyl tropane derivatives for therapy |
10/11/2006 | CN1279020C Method of removing thallus and macromolecular protein from acrylamide produced via biological process |
10/10/2006 | US7119229 Having anticancer, anti-proliferous and anti-inflammatory effects and immunosuppressive and muscle relaxing functions |
10/10/2006 | US7119223 Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators |
10/10/2006 | CA2268799C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same |
10/10/2006 | CA2158862C Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same |
10/05/2006 | WO2006105386A1 Cdk2 inhibitors |
10/05/2006 | WO2006104826A2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
10/05/2006 | WO2006103503A1 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists |
10/05/2006 | WO2006103401A2 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
10/05/2006 | WO2005065361A3 Compounds and compositions for treating dysproliferative diseases, and methods of use thereof |
10/05/2006 | US20060223726 Photo-labile pro-fragrance conjugates |
10/05/2006 | US20060223152 Optically active 2-allylcarboxylic acid derivative and process for producing the same |
10/05/2006 | US20060219545 Method for the purification of dimethylacetamide (dmac) |
10/05/2006 | CA2602566A1 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists |
10/05/2006 | CA2602075A1 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use |
10/04/2006 | EP1707559A1 Method of enanthio-selective nucleophilic addition reaction for conversion of enamide to imine and method of synthesizing alpha amino-gamma-keto acid ester |
10/04/2006 | EP1706377A1 Cis-alkoxyspiro-substituted tetramic acid derivatives |
10/04/2006 | EP1706371A1 Aryl aniline derivatives as beta2 adrenergic receptor agonists |
10/04/2006 | EP1534658A4 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
10/04/2006 | EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
10/04/2006 | CN1277807C Process for the preparation of aminoalcohol and (1S, 4Rú®or (1R, 4S)-1-amino-4-(methylol)-2-cyclopentene or its salts |
10/03/2006 | US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
10/03/2006 | US7115778 Process for the preparation of iopamidol |
10/03/2006 | US7115777 For therapy of hypertension, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, complications resulting from diabetes, such as nephropathy, vasculopathy and neuropathy, diseases of the coronary vessels, restenosis following angioplasty |
10/03/2006 | US7115768 Particularly (adamantylcarbonylamino)acetic acid derivatives |
10/03/2006 | US7115752 Substituted cyclic compounds |
10/03/2006 | US7115750 Melanin concentrating hormone antagonist |
10/03/2006 | US7115249 producing radiolabelled 6-L-fluorodopa on support; deblocking, deprotecting; for use in positron emission tomography; kits |
10/03/2006 | CA2234638C New bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity |
09/28/2006 | WO2006102645A1 Biaryl derived amide modulators of vanilloid vr1 receptor |
09/28/2006 | WO2006102423A1 Alpha ketoamide compounds as cysteine protease inhibitors |
09/28/2006 | WO2006101422A1 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof |
09/28/2006 | WO2006100731A1 Method for acetylating 5-amino-2,4,6-triiodoisophthalic acid derivative |
09/28/2006 | WO2006100568A1 Preparation of optically pure beta-amino acids having affinity for the alpha-2-delta protein |
09/28/2006 | WO2006100563A1 Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide |
09/28/2006 | WO2006100502A1 11-beta-hydroxysteroid dehydrogenase inhibitors |
09/28/2006 | WO2004069146A3 L-dopa amide derivatives and uses thereof |
09/28/2006 | US20060217533 Production of N-acyl compounds |
09/28/2006 | CA2603305A1 Alpha ketoamide compounds as cysteine protease inhibitors |
09/28/2006 | CA2602583A1 Biaryl derived amide modulators of vanilloid vr1 receptor |
09/28/2006 | CA2602545A1 Phenyl-n-acyl derivatives of amines and amino acids, a process for the preparation thereof, a pharmaceutical composition and the use thereof |
09/28/2006 | CA2602418A1 Preparation of optically pure beta-amino acids having affinity for the alpha-2-delta protein |
09/28/2006 | CA2602112A1 Sulfonyl containing compounds as cysteine protease inhibitors |
09/28/2006 | CA2598589A1 11-beta-hydroxysteroid dehydrogenase inhibitors |
09/27/2006 | EP1705174A1 Selective androgen receptor modulators and methods of use thereof |
09/27/2006 | EP1705173A1 Binaphthol deratives and their use in optical resolution or optical transformation |
09/27/2006 | EP1704856A1 Hsp90 family protein inhibitor |
09/27/2006 | EP1703797A2 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |